₹1214.8050.404.33%(1D)
Performance Stats for Aurobindo Pharma
Day Range
Low: ₹1162.40
High: ₹1216.30
52 Week Range
Low: ₹1010.00
High: ₹1278.60
Open Price
1166.00Previous Close
1164.40Volume
2794251.00Open Price
1166.00Previous Close
1164.40Volume
2794251.00Fundamentals of Aurobindo Pharma
ROCE
10.82%
EPS
₹36.91
Dividend Yield
0%
P/E Ratio
38.55
P/B Ratio
3.28
Debt to Equity
0.19
Current Ratio
1.25
Sales Growth
0.89%
Profit Growth
11.13%
EBIT Growth
9.45%
Financials of Aurobindo Pharma
All values in Rs. Cr
All values in Rs. Cr
All values in Rs. Cr
Share Holding Pattern of Aurobindo Pharma
About Aurobindo Pharma
Aurobindo Pharma Limited (APL), one of the worlds top 5 manufacturers of semi synthetic penicillins was incorporated in December 1986 as a private limited company. Mr. P.V.Ramaprasad Reddy, Mr. K.Nityananda Reddy and a small, highly committed group o...
Read more
Similar Sector Stocks
| Stocks | CMP |
| Alembic Pharma | ₹743.45 0.99% |
| Cipla | ₹1344.3 1.33% |
| Glenmark Pharmaceuticals | ₹2085.5 1.31% |
| Ipca Laboratories | ₹1521 0.38% |
Most Viewed Stocks
Open Interest (OI)
Aurobindo Pharma Options
| Price | OI | Volume |
Events Related to Aurobindo Pharma
Board Meeting
Feb 9, 2026
Board Meeting
Nov 5, 2025
AGM
Sep 10, 2025
Book Closure
Sep 8, 2025
Dividend
Aug 8, 2025
News About Aurobindo Pharma
?Aurobindo Pharma among 4 F&O stocks saw a high increase in futures open interest
Feb 19, 2026
Aurobindo Pharma Shares Fall After USFDA Flags Severe Contamination, Data Integrity Failures
Feb 18, 2026
Aurobindo Pharma Shares In Focus After Q3 Results; This Brokerage Maintains A Bullish View — More Details Inside
Feb 11, 2026
Q3 Results Live Updates: Gulf Oil Declared Rs 21 Dividend; BSE Profit, Revenue Grew
Feb 9, 2026
Q3 Results Today: Bata India, Zydus Lifesciences, Aurobindo Pharma, Pfizer Among 184 Firms To Declare Earnings
Feb 9, 2026
